-
Observational studies show excellent efficacy of two-dose regimen of Pfizer or AZ against the Delta variant dramatically reducing the risk of hospitalization. #vaccineswork
Medical Mythbusting Commentary for June 15, 2021 Source:2 Pfizer COVID-19 vaccines more effective than AstraZeneca against Delta variant, data says Reference:SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectivenessEffectiveness of COVID-19 vaccines against hospital admission with the Delta (B.1.617.2) Variant
tagged:
-
What should your #seconddose of #covidvaccine be if 1st was AZ? Factors include wait-time/availability, Delta variant prevalence, occupational risks, and study evidence. Answer seems to leaning to Pfizer or Moderna as 2nd dose of choice.
Medical Mythbusting Commentary for June 14, 2021 Source:Ontario shortens wait between AstraZeneca doses from 12 to 8 weeksMix-and-match COVID vaccines trigger potent immune response
tagged:
-
Sunday House Call, #794, June 13, 2021: The Heart of the Matter. @drlabos #myocarditis #mRNAvaccines
A review by Dr. Christopher Labos from the McGill Office for Science and Society of what we know about the mRNA vaccines and the possible but as yet unproven link with myocarditis/pericarditis in predominantly males between the ages of 14 and 25. Your calls about: Shingles reactivation. Why this is happening? How to respond to…
tagged:
-
CDC and other regulators working to assess risk and if there is a causal relationship between mRNA vaccines and myo/pericarditis seen predominately in a small number of males 16-24 years old after 2nd dose.
Medical Mythbusting Commentary for June 11, 2021 Source:Heart inflammation in young men higher than expected after Pfizer, Moderna vaccines: U.S. CDC Reference:FDA COVID-19 Vaccine Safety Updates
tagged:
-
Ontario Medical Association estimates that there is a backlog 16 million medical services including mental health support, surgeries, cancer screening, monitoring of chronic disease, MRIs, and CT scans amongst the myriad of other services.
Medical Mythbusting Commentary for June 10, 2021 Source:Ontario has a backlog of nearly 16 million medical services: Ontario Medical Association
-
FDA approval process questioned as it approves new early-stage $56K US/year treatment for Alzheimer’s despite its own panel founding insufficient evidence of efficacy. Only when company changed the study endpoint did it show efficacy compared to placebo.
Medical Mythbusting Commentary for June 8, 2021 Source:In controversial decision, FDA approves first new Alzheimer’s disease drug in nearly 20 years
tagged:
-
Wuhan lab leak hypothesis continues to percolate as non-experts claim SARS-CoV-2 has “a genetic footprint that has never been observed in a natural coronavirus.” Geneticists’/virologists’ expertise/comments needed to help many discern fact from fiction.
Medical Mythbusting Commentary for June 6, 2021 Source:The Science Suggests a Wuhan Lab LeakLab leak Covid-19 theory is like something out of a comic book, virologist says
-
A step forward for management of obesity with approval of semaglutide by FDA. @YoniFreedhoff joins me to discuss fat shaming, weight bias and how we need to turn this around and help those suffering with obesity as we would with any other chronic disease.
Sunday House Call, #793, June 6, 2021 A rapid home blood test to check if you are immune to Sars-CoV-2 developed by Johns Hopkins Your calls: Is disinfecting surfaces and packages still a thing during the pandemic? What happens to sperm cells after a vasectomy? A caller has had the AZ vaccine and can get…
tagged:
-
Pfizer vaccine recipients have lower neutralizing antibodies targeting delta variant up to three months after first dose. Outcome data needed to determine if this translates into less efficacy. Study concludes second dose interval needs to be shortened.
Medical Mythbusting Commentary for June 4, 2021 Source:Pfizer vaccine recipients have lower antibodies targeting Indian variant – studyPfizer-BioNTech vaccine recipients have lower antibody levels targeting the Delta variant Reference:Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination
tagged: